id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-D-0446-0025,FDA,FDA-2013-D-0446,Expanded Access to Investigational Drugs for Treatment Use: Questions and Answers; Guidance for Industry,Other,Guidance,2025-11-17T05:00:00Z,2025,11,2025-11-17T05:00:00Z,,2025-11-17T19:59:51Z,,1,0,09000064b90857a2
FDA-2013-D-0446-0024,FDA,FDA-2013-D-0446,Expanded Access to Investigational Drugs for Treatment Use: Questions and Answers; Guidance for Industry; Availability,Notice,Notice of Availability,2025-11-17T05:00:00Z,2025,11,2025-11-17T05:00:00Z,,2025-11-17T19:38:16Z,2025-19984,0,0,09000064b9085097
FDA-2013-D-0446-0016,FDA,FDA-2013-D-0446,Expanded Access to Investigational Drugs for Treatment Use; Questions and Answers; Guidance for Industry; Revised Draft Guidance,Other,Guidance,2022-11-04T04:00:00Z,2022,11,2022-11-04T04:00:00Z,2023-01-04T04:59:59Z,2024-11-12T23:46:50Z,,1,0,090000648547b9f2
FDA-2013-D-0446-0015,FDA,FDA-2013-D-0446,Expanded Access to Investigational Drugs for Treatment Use: Questions and Answers; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2022-11-02T04:00:00Z,2022,11,,,2022-11-02T13:00:13Z,2022-23785,0,0,090000648547b466
FDA-2013-D-0446-0013,FDA,FDA-2013-D-0446,Guidance for Industry on Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers,Other,Guidance,2016-06-03T04:00:00Z,2016,6,,,2022-11-02T13:09:37Z,,0,0,090000648200de17
FDA-2013-D-0446-0012,FDA,FDA-2013-D-0446,Expanded Access to Investigational Drugs for Treatment Use- Questions and Answers; Guidance for Industry; Availability,Notice,Notice of Availability,2016-06-03T04:00:00Z,2016,6,2016-06-03T04:00:00Z,,2016-06-03T14:20:52Z,2016-13165,0,0,090000648200d007
FDA-2013-D-0446-0002,FDA,FDA-2013-D-0446,Draft Guidance for Industry on Expanded Access to Investigational Drugs for Treatment Use--Questions and Answers,Other,Guidance,2013-05-09T04:00:00Z,2013,5,2013-05-09T04:00:00Z,,2024-11-12T05:15:16Z,,1,0,09000064812cd344
FDA-2013-D-0446-0001,FDA,FDA-2013-D-0446,Draft Guidance for Industry on Expanded Access to Investigational Drugs for Treatment Use--Questions and Answers; Availability,Notice,Notice of Availability,2013-05-09T04:00:00Z,2013,5,2013-05-09T04:00:00Z,2013-07-09T03:59:59Z,2014-06-19T01:01:23Z,2013-11005,0,0,09000064812cd343